We integrated the results from the prior establishment of the IPF-ARG transcription factor and miRNA networks, along with the drug target analysis of CDH3, EDNRB, MAOA, and PLA2G1B. The gene discussed is PLA2G1B; the disease is idiopathic pulmonary fibrosis.